Web-Savvy Firms Embrace Electronic Registration & Listing Proposal
This article was originally published in The Gray Sheet
Executive Summary
Companies attending FDA's April 20 and 21 grassroots meetings in San Jose and Irvine, California, respectively, supported FDA's plan to require that all medical device registration and listing (R&L) submissions be made to a secure FDA website, according to an agency summary of the meetings.